Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 563M | 540M | 523M | 467M |
| Cost of revenue | 202M | 199M | 186M | 178M |
| Gross profit | 361M | 341M | 337M | 289M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 77M | 73M | 58M | 65M |
| Operating income | 247M | 254M | 234M | 184M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 262M | 254M | 240M | 189M |
| Tax provision | 52M | 47M | 50M | 40M |
| Net income | 210M | 207M | 189M | 149M |
| Basic EPS | 0.3 | 0.3 | 0.3 | 0.2 |
| Diluted EPS | 0.3 | 0.3 | 0.3 | 0.2 |
| Basic average shares | 609.7M | 609.7M | 609.7M | 609.6M |
| Diluted average shares | 609.8M | 609.8M | 609.8M | 609.9M |
| EBITDA | 300M | 304M | 286M | 229M |
| Net income from continuing op. | 262M | 254M | 240M | 189M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |